175 related articles for article (PubMed ID: 12605967)
1. Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma.
Eich HT; Eich D; Micke O; Süttzer H; Casper C; Krieg T; Müller RP
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):899-906. PubMed ID: 12605967
[TBL] [Abstract][Full Text] [Related]
2. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience.
De Felice F; Grapulin L; Pieroni A; Salerno F; D'Elia GM; Pulsoni A; Musio D; Tombolini V
Ann Hematol; 2018 Dec; 97(12):2411-2416. PubMed ID: 30094511
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications.
Yap LM; Blum R; Foley P; McCormack C; Turner H; Seymour JF; Prince HM
Australas J Dermatol; 2003 May; 44(2):110-5. PubMed ID: 12752183
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy in the management of localized primary cutaneous B-cell lymphoma.
Pashtan I; Mauch PM; Chen YH; Dorfman DM; Silver B; Ng AK
Leuk Lymphoma; 2013 Apr; 54(4):726-30. PubMed ID: 22916994
[TBL] [Abstract][Full Text] [Related]
8. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
[TBL] [Abstract][Full Text] [Related]
9. Treatment of primary cutaneous B-cell lymphoma with radiotherapy.
Ulutin HC; Oztürk B; Ongürü O; Kuzhan O; Arpaci F; Ozet A
Radiat Med; 2005 Jun; 23(4):292-5. PubMed ID: 16012406
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy.
Rijlaarsdam JU; Toonstra J; Meijer OW; Noordijk EM; Willemze R
J Clin Oncol; 1996 Feb; 14(2):549-55. PubMed ID: 8636770
[TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy.
Akhtari M; Reddy JP; Pinnix CC; Allen PK; Osborne EM; Gunther JR; Milgrom SA; Smith GL; Wogan CF; Fowler N; Rodriguez MA; Dabaja B
Leuk Lymphoma; 2016; 57(1):34-8. PubMed ID: 25860237
[TBL] [Abstract][Full Text] [Related]
12. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.
Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN
Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204
[TBL] [Abstract][Full Text] [Related]
14. Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa.
Vandersee S; Terhorst D; Humme D; Beyer M
J Am Acad Dermatol; 2014 Apr; 70(4):709-715. PubMed ID: 24433874
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Daniëls LA; Neelis KJ; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Velstra B; Veraart JCJM; Roach REJ; Vermeer MH; Quint KD
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1279-1285. PubMed ID: 28958772
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous B-cell lymphoma: review and current concepts.
Pandolfino TL; Siegel RS; Kuzel TM; Rosen ST; Guitart J
J Clin Oncol; 2000 May; 18(10):2152-68. PubMed ID: 10811681
[TBL] [Abstract][Full Text] [Related]
20. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
